Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges

Cardiovascular Engineering and Technology

Volumn 2, Issue 3, 2011, Pages 137-148

  Kumar, Vivek A ^a   Brewster, Luke P ^b   Caves, Jeffrey M ^c   Chaikof, Elliot L ^a,b,c,d  

^a Emory University   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

Biological requirements of blood vessels; Blood vessels; Cardiovascular disease; Mechanical requirements of blood vessels; Stems cells; Vascular tissue engineering

Indexed keywords

BIOLOGICAL REQUIREMENTS OF BLOOD VESSELS; CARDIO-VASCULAR DISEASE; MECHANICAL REQUIREMENTS; STEMS CELLS; VASCULAR TISSUE ENGINEERING;

BLOOD; CYTOLOGY; TISSUE; TISSUE ENGINEERING;

BLOOD VESSELS;

CD34 ANTIBODY; DACRON; FIBRIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYURETHAN; STROMAL CELL DERIVED FACTOR 1; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADATION; BIOENGINEERING; BLOOD VESSEL; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHEMICAL MODIFICATION; COST EFFECTIVENESS ANALYSIS; ENDOTHELIUM CELL; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IMMUNE RESPONSE; MACROPHAGE; MECHANICAL TORSION; MECHANICS; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SMOOTH MUSCLE FIBER; STATIC ELECTRICITY; TISSUE ENGINEERING; TISSUE GROWTH;

EID: 79960966690     PISSN: 1869408X     EISSN: 18694098     Source Type: Journal    
DOI: 10.1007/s13239-011-0049-3     Document Type: Review

References (170)

1. Allen, J., et al. Characterization of porcine circulating progenitor cells: toward a functional endothelium. Tissue Eng. Part A 14(1): 183-194, 2008.
2. Allen, J. B., et al. Toward engineering a human neoendothelium with circulating progenitor cells. Stem Cells 28(2): 318-328, 2010.
3. Amarnath, L. P., A. Srinivas, and A. Ramamurthi. In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials 27(8): 1416-1424, 2006.
4. ANSI/AAMI/ISO. Cardiovascular Implants-Tubular Vascular Prostheses, 2001.
5. Ariganello, M. B., R. S. Labow, and J. M. Lee. In vitro response of monocyte-derived macrophages to a decellularized pericardial biomaterial. J. Biomed. Mater. Res. A 93(1): 280-288, 2010.
6. Ariganello, M. B., et al. Macrophage differentiation and polarization on a decellularized pericardial biomaterial. Biomaterials 32(2): 439-449, 2011.
7. Arrigoni, C., D. Camozzi, and A. Remuzzi. Vascular tissue engineering. Cell Transplant. 15(Suppl. 1): S119-S125, 2006.
8. ASTM Committee F-4 on Medical Surgical, M. D. Vascular Graft Update: Safety and Performance. Philadelphia, PA: ASTM, 1986.
9. Badylak, S. F., et al. Comparison of the resistance to infection of intestinal submucosa arterial autografts versus polytetrafluoroethylene arterial prostheses in a dog model. J. Vasc. Surg. 19(3): 465-472, 1994.
10. Ball, S. G., C. A. Shuttleworth, and C. M. Kielty. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J. Cell. Mol. Med. 11(5): 1012-1030, 2007.
11. Bowlin, G. L., et al. The persistence of electrostatically seeded endothelial cells lining a small diameter expanded polytetrafluoroethylene vascular graft. J. Biomater. Appl. 16(2): 157-173, 2001.
12. Byrne, J., P. Feustel, and R. C. Darling, III. Primary closure, routine patching, and eversion endarterectomy: what is the current state of the literature supporting use of these techniques? Semin. Vasc. Surg. 20(4): 226-235, 2007.
13. Campbell, G. R., and J. H. Campbell. Development of tissue engineered vascular grafts. Curr. Pharm. Biotechnol. 8(1): 43-50, 2007.
14. Campbell, J. H., J. L. Efendy, and G. R. Campbell. Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 85(12): 1173-1178, 1999.
15. Campbell, G. R., et al. The peritoneal cavity as a bioreactor for tissue engineering visceral organs: bladder, uterus and vas deferens. J. Tissue Eng. Regen. Med. 2(1): 50-60, 2008.
16. Campoccia, D., et al. Human neutrophil chemokinesis and polarization induced by hyaluronic acid derivatives. Biomaterials 14(15): 1135-1139, 1993.
17. Caves, J. M., et al. The use of microfiber composites of elastin-like protein matrix reinforced with synthetic collagen in the design of vascular grafts. Biomaterials 31(27): 7175-7182, 2010.
18. Chan-Park, M. B., et al. Biomimetic control of vascular smooth muscle cell morphology and phenotype for functional tissue-engineered small-diameter blood vessels. J. Biomed. Mater. Res. A 88(4): 1104-1121, 2009.
19. Chaouat, M., et al. The evaluation of a small-diameter polysaccharide-based arterial graft in rats. Biomaterials 27(32): 5546-5553, 2006.
20. Chemla, E. S., and M. Morsy. Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access. Br. J. Surg. 96(1): 34-39, 2009.
21. Cho, S. W., et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann. Surg. 241(3): 506-515, 2005.
22. Chuang, T. W., and K. S. Masters. Regulation of polyurethane hemocompatibility and endothelialization by tethered hyaluronic acid oligosaccharides. Biomaterials 30(29): 5341-5351, 2009.
23. Clarke, D. R., et al. Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann. Thorac. Surg. 71(5 Suppl.): S433-S436, 2001.
24. Cummings, C. L., et al. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25(17): 3699-3706, 2004.
25. Dahl, S. L., M. E. Vaughn, and L. E. Niklason. An ultrastructural analysis of collagen in tissue engineered arteries. Ann. Biomed. Eng. 35(10): 1749-1755, 2007.
26. Dahl, S. L., et al. Mechanical properties and compositions of tissue engineered and native arteries. Ann. Biomed. Eng. 35(3): 348-355, 2007.
27. Dahl, S. L., et al. Readily available tissue-engineered vascular grafts. Sci. Transl. Med. 3(68): 68ra9, 2011.
28. Daniel, J. M., and D. G. Sedding. Circulating smooth muscle progenitor cells in arterial remodeling. J. Mol. Cell. Cardiol. 50(2): 273-279, 2011.
29. Das, N., et al. Results of a seven-year, single-centre experience of the long-term outcomes of bovine ureter grafts used as novel conduits for haemodialysis fistulas. Cardiovasc. Intervent. Radiol. 1-6, 2011.
30. Davis, N. P., et al. Sustained axial loading lengthens arteries in organ culture. Ann. Biomed. Eng. 33(7): 867-877, 2005.
31. Derham, C., et al. Tissue engineering small-diameter vascular grafts: preparation of a biocompatible porcine ureteric scaffold. Tissue Eng. Part A 14(11): 1871-1882, 2008.
32. Deutsch, M., et al. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J. Vasc. Surg. 49(2): 352-362, 2009; discussion 362.
33. Dorafshar, A. H., et al. Interposition grafts for difficult carotid artery reconstruction: a 17-year experience. Ann. Vasc. Surg. 22(1): 63-69, 2008.
34. Drilling, S., J. Gaumer, and J. Lannutti. Fabrication of burst pressure competent vascular grafts via electrospinning: effects of microstructure. J. Biomed. Mater. Res. A 88(4): 923-934, 2009.
35. Ehrbar, M., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ. Res. 94(8): 1124-1132, 2004.
36. Fernandez, P., and A. R. Bausch. The compaction of gels by cells: a case of collective mechanical activity. Integr. Biol. (Camb.) 1(3): 252-259, 2009.
37. Fidkowski, C., et al. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng. 11(1-2): 302-309, 2005.
38. Fitzpatrick, J. C., P. M. Clark, and F. M. Capaldi. Effect of decellularization protocol on the mechanical behavior of porcine descending aorta. Int. J. Biomater. 2010: 620503 (11 pp), 2010.
39. Gan, Q., et al. Smooth muscle cells and myofibroblasts use distinct transcriptional mechanisms for smooth muscle alpha-actin expression. Circ. Res. 101(9): 883-892, 2007.
40. Gauvin, R., et al. A novel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs. Tissue Eng. Part A 16(5): 1737-1747, 2010.
41. Goldstein, L. J., et al. Carotid artery stenting is safe and associated with comparable outcomes in men and women. J. Vasc. Surg. 49(2): 315-323, 2009; discussion 323-4.
42. Gong, Z., and L. E. Niklason. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 22(6): 1635-1648, 2008.
43. Gong, Z., et al. Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells. Tissue Eng. Part A 15(2): 319-330, 2009.
44. Goodman, S. L. Sheep, pig, and human platelet-material interactions with model cardiovascular biomaterials. J. Biomed. Mater. Res. 45(3): 240-250, 1999.
45. Gotherstrom, C. Immunomodulation by multipotent mesenchymal stromal cells. Transplantation 84(1 Suppl.): S35-S37, 2007.
46. Grassl, E. D., T. R. Oegema, and R. T. Tranquillo. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J. Biomed. Mater. Res. 60(4): 607-612, 2002.
47. Greenwald, S. E., and C. L. Berry. Improving vascular grafts: the importance of mechanical and haemodynamic properties. J. Pathol. 190(3): 292-299, 2000.
48. Gui, L., et al. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue Eng. Part A 15(9): 2665-2676, 2009.
49. Han, H. C., D. N. Ku, and R. P. Vito. Arterial wall adaptation under elevated longitudinal stretch in organ culture. Ann. Biomed. Eng. 31(4): 403-411, 2003.
50. Hancock, W. W. Delayed xenograft rejection. World J. Surg. 21(9): 917-923, 1997.
51. Hashi, C. K., et al. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts. Proc. Natl Acad. Sci. USA 104(29): 11915-11920, 2007.
52. He, W., et al. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J. Biomed. Mater. Res. A 90(1): 205-216, 2009.
53. Heidenhain, C., et al. Polymer coating of porcine decellularized and cross-linked aortic grafts. J. Biomed. Mater. Res. B Appl. Biomater. 94(1): 256-263, 2010.
54. Hjortnaes, J., et al. Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study. Tissue Eng. Part C Methods 16(4): 597-607, 2010.
55. Hong, Y., et al. A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend. Biomaterials 30(13): 2457-2467, 2009.
56. Isaka, M., et al. Experimental study on stability of a high-porosity expanded polytetrafluoroethylene graft in dogs. Ann. Thorac. Cardiovasc. Surg. 12(1): 37-41, 2006.
57. Isenberg, B. C., and R. T. Tranquillo. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 31(8): 937-949, 2003.
58. Iwakura, A., et al. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108(25): 3115-3121, 2003.
59. Iwasaki, K., et al. Bioengineered three-layered robust and elastic artery using hemodynamically-equivalent pulsatile bioreactor. Circulation 118(14 Suppl.): S52-S57, 2008.
60. Jiang, Z., et al. Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis. Am. J. Physiol. Heart Circ. Physiol. 297(4): H1200-H1207, 2009.
61. Jorgensen, C. Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells? Stem Cell Res. Ther. 1(2): 15, 2010.
62. Kaushiva, A., et al. A biodegradable vascularizing membrane: a feasibility study. Acta Biomater. 3(5): 631-642, 2007.
63. Kibbe, M. R., et al. Citric acid-based elastomers provide a biocompatible interface for vascular grafts. J. Biomed. Mater. Res. A 93(1): 314-324, 2010.
64. Kielty, C. M., et al. Applying elastic fibre biology in vascular tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362(1484): 1293-1312, 2007.
65. Klinger, R. Y., et al. Relevance and safety of telomerase for human tissue engineering. Proc. Natl Acad. Sci. USA 103(8): 2500-2505, 2006.
66. Konig, G., et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials 30(8): 1542-1550, 2009.
67. Ku, D. N., and D. P. Giddens. Pulsatile flow in a model carotid bifurcation. Arteriosclerosis 3(1): 31-39, 1983.
68. Ku, D. N., et al. Hemodynamics of the normal human carotid bifurcation: in vitro and in vivo studies. Ultrasound Med. Biol. 11(1): 13-26, 1985.
69. Ku, D. N., et al. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 5(3): 293-302, 1985.
70. Laurent, S., et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 23(6 Pt 2): 878-883, 1994.
71. Lee, M. H., et al. Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng. Part B Rev. 16(1): 41-54, 2010.
72. L'Heureux, N., T. N. McAllister, and L. M. de la Fuente. Tissue-engineered blood vessel for adult arterial revascularization. N. Engl. J. Med. 357(14): 1451-1453, 2007.
73. L'Heureux, N., et al. A completely biological tissue-engineered human blood vessel. FASEB J. 12(1): 47-56, 1998.
74. L'Heureux, N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 12(3): 361-365, 2006.
75. L'Heureux, N., et al. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat. Clin. Pract. Cardiovasc. Med. 4(7): 389-395, 2007.
76. Li, C., A. Hill, and M. Imran. In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. J. Biomater. Sci. Polym. Ed. 16(7): 875-891, 2005.
77. Liu, J. Y., et al. Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovasc. Res. 75(3): 618-628, 2007.
78. Liu, G. F., et al. Decellularized aorta of fetal pigs as a potential scaffold for small diameter tissue engineered vascular graft (Engl). Chin. Med. J. 121(15): 1398-1406, 2008.
79. Lloyd-Jones, D., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121(7): e46-e215, 2010.
80. Long, J. L., and R. T. Tranquillo. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol. 22(4): 339-350, 2003.
81. Lopez-Soler, R. I., et al. Development of a mouse model for evaluation of small diameter vascular grafts. J. Surg. Res. 139(1): 1-6, 2007.
82. Lund, A. W., J. P. Stegemann, and G. E. Plopper. Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture. Stem Cells Dev. 18(2): 331-341, 2009.
83. Matsumura, G., et al. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108(14): 1729-1734, 2003.
84. McAllister, T. N., et al. Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regen. Med. 3(6): 925-937, 2008.
85. McAllister, T. N., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373(9673): 1440-1446, 2009.
86. McKee, J. A., et al. Human arteries engineered in vitro. EMBO Rep. 4(6): 633-638, 2003.
87. Meinhart, J., M. Deutsch, and P. Zilla. Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts. ASAIO J. 43(5): M515-M521, 1997.
88. Mine, Y., et al. Suture retention strength of expanded polytetrafluoroethylene (ePTFE) graft. Acta Med. Okayama 64(2): 121-128, 2010.
89. Mirensky, T. L., et al. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J. Pediatr. Surg. 44(6): 1127-1132, 2009; discussion 1132-3.
90. Mitchell, S. L., and L. E. Niklason. Requirements for growing tissue-engineered vascular grafts. Cardiovasc. Pathol. 12(2): 59-64, 2003.
91. Motlagh, D., et al. Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials 27(24): 4315-4324, 2006.
92. Motlagh, D., et al. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A 82(4): 907-916, 2007.
93. Narita, Y., et al. Decellularized ureter for tissue-engineered small-caliber vascular graft. J. Artif. Organs 11(2): 91-99, 2008.
94. Neff, L. P., et al. Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo. J. Vasc. Surg. 53(2): 426-434, 2011.
95. Nieponice, A., et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 29(7): 825-833, 2008.
96. Niklason, L. E. Techview: medical technology. Replacement arteries made to order. Science 286(5444): 1493-1494, 1999.
97. Niklason, L. E., et al. Functional arteries grown in vitro. Science 284(5413): 489-493, 1999.
98. Noel, D., et al. Multipotent mesenchymal stromal cells and immune tolerance. Leuk. Lymphoma 48(7): 1283-1289, 2007.
99. Opitz, F., et al. Tissue engineering of aortic tissue: dire consequence of suboptimal elastic fiber synthesis in vivo. Cardiovasc. Res. 63(4): 719-730, 2004.
100. Owens, G. K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75(3): 487-517, 1995.
101. Owens, G. K. Role of mechanical strain in regulation of differentiation of vascular smooth muscle cells. Circ. Res. 79(5): 1054-1055, 1996.
102. Owens, G. K. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp. 283: 174-191, 2007; discussion 191-3, 238-41.
103. Pektok, E., et al. Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118(24): 2563-2570, 2008.
104. Petersen, T. H., et al. Utility of telomerase-pot1 fusion protein in vascular tissue engineering. Cell Transplant. 19(1): 79-87, 2010.
105. Poh, M., et al. Blood vessels engineered from human cells. Lancet 365(9477): 2122-2124, 2005.
106. Qi, J., et al. Modulation of collagen gel compaction by extracellular ATP is MAPK and NF-kappaB pathways dependent. Exp. Cell Res. 315(11): 1990-2000, 2009.
107. Quillard, T., et al. Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 28(12): 2258-2265, 2008.
108. Rachev, A., Z. Dominguez, and R. Vito. System and method for investigating arterial remodeling. J. Biomech. Eng. 131: 104501, 2009.
109. Ravi, S., Z. Qu, and E. L. Chaikof. Polymeric materials for tissue engineering of arterial substitutes. Vascular 17(Suppl. 1): S45-S54, 2009.
110. Roeder, R., et al. Compliance, elastic modulus, and burst pressure of small-intestine submucosa (SIS), small-diameter vascular grafts. J. Biomed. Mater. Res. 47(1): 65-70, 1999.
111. Roh, J. D., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc. Natl Acad. Sci. USA 107(10): 4669-4674, 2010.
112. Salem, H. K., and C. Thiemermann. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28(3): 585-596, 2010.
113. Salom, R. N., J. A. Maguire, and W. W. Hancock. Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology 30(1): 24-29, 1998.
114. Sandusky, G. E., G. C. Lantz, and S. F. Badylak. Healing comparison of small intestine submucosa and ePTFE grafts in the canine carotid artery. J. Surg. Res. 58(4): 415-420, 1995.
115. Sarkar, S., et al. Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used. J. Vasc. Surg. 44(4): 846-852, 2006.
116. Sarkar, S., et al. The mechanical properties of infrainguinal vascular bypass grafts: their role in influencing patency. Eur. J. Vasc. Endovasc. Surg. 31(6): 627-636, 2006.
117. Sarkar, S., et al. Addressing thrombogenicity in vascular graft construction. J. Biomed. Mater. Res. B Appl. Biomater. 82(1): 100-108, 2007.
118. Schaner, P. J., et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J. Vasc. Surg. 40(1): 146-153, 2004.
119. Seliktar, D., et al. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann. Biomed. Eng. 28(4): 351-362, 2000.
120. Sell, S. A., et al. Electrospun polydioxanone-elastin blends: potential for bioresorbable vascular grafts. Biomed. Mater. 1(2): 72-80, 2006.
121. Sell, S. A., et al. Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering. Adv. Drug Deliv. Rev. 61(12): 1007-1019, 2009.
122. Shaikh, F. M., et al. Fibrin: a natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 188(4): 333-346, 2008.
123. Sharp, M. A., et al. A cautionary case: the SynerGraft vascular prosthesis. Eur. J. Vasc. Endovasc. Surg. 27(1): 42-44, 2004.
124. Shaw, J. A., et al. Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease. J. Am. Coll. Cardiol. 39(10): 1637-1643, 2002.
125. Shi, Y., et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20(5): 510-518, 2010.
126. Shin'oka, T., Y. Imai, and Y. Ikada. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344(7): 532-533, 2001.
127. Shin'oka, T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 129(6): 1330-1338, 2005.
128. Solan, A., S. L. Dahl, and L. E. Niklason. Effects of mechanical stretch on collagen and cross-linking in engineered blood vessels. Cell Transplant. 18(8): 915-921, 2009.
129. Soletti, L., et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater. 6(1): 110-122, 2010.
130. Soletti, L., et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater. 6(1): 110-122, 2010.
131. Spark, J. I., et al. Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts. Br. J. Surg. 95(5): 582-585, 2008.
132. Stekelenburg, M., et al. Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts. Tissue Eng. Part A 15(5): 1081-1089, 2009.
133. Sussman, M. A. Showing up isn't enough for vascularization: persistence is essential. Circ. Res. 103(11): 1200-1201, 2008.
134. Sutherland, K., et al. Degradation of biomaterials by phagocyte-derived oxidants. J. Clin. Invest. 92(5): 2360-2367, 1993.
135. Swartz, D. D., J. A. Russell, and S. T. Andreadis. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am. J. Physiol. Heart Circ. Physiol. 288(3): H1451-H1460, 2005.
136. Syedain, Z. H., et al. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 32(3): 714-722, 2010.
137. Tai, N. R., et al. In vivo femoropopliteal arterial wall compliance in subjects with and without lower limb vascular disease. J. Vasc. Surg. 30(5): 936-945, 1999.
138. Tai, N. R., et al. Compliance properties of conduits used in vascular reconstruction. Br. J. Surg. 87(11): 1516-1524, 2000.
139. Timaran, C. H., et al. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J. Vasc. Surg. 48(2): 355-360, 2008; discussion 360-1.
140. Torikai, K., et al. A self-renewing, tissue-engineered vascular graft for arterial reconstruction. J. Thorac. Cardiovasc. Surg. 136(1): 37-45, 45 e1 2008.
141. Uccelli, A., V. Pistoia, and L. Moretta. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28(5): 219-226, 2007.
142. Urbich, C., and S. Dimmeler. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95(4): 343-353, 2004.
143. van Andel, C. J., P. V. Pistecky, and C. Borst. Mechanical properties of porcine and human arteries: implications for coronary anastomotic connectors. Ann. Thorac. Surg. 76(1): 58-64, 2003; discussion 64-5.
144. Villalona, G. A., et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng. Part B Rev. 16(3): 341-350, 2010.
145. Wagenseil, J. E., and R. P. Mecham. Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 89(3): 957-989, 2009.
146. Walter, D. H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105(25): 3017-3024, 2002.
147. Wang, C., et al. A new vascular prosthesis coated with polyamino-acid urethane copolymer (PAU) to enhance endothelialization. J. Biomed. Mater. Res. 62(3): 315-322, 2002.
148. Wang, S., et al. Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. Biomacromolecules 10(8): 2240-2244, 2009.
149. Wayman, B. H., et al. Arteries respond to independent control of circumferential and shear stress in organ culture. Ann. Biomed. Eng. 36(5): 673-684, 2008.
150. Webb, A. R., et al. In vitro characterization of a compliant biodegradable scaffold with a novel bioreactor system. Ann. Biomed. Eng. 35(8): 1357-1367, 2007.
151. Weinberg, C. B., and E. Bell. A blood vessel model constructed from collagen and cultured vascular cells. Science 231(4736): 397-400, 1986.
152. Werner, N., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93(2): e17-e24, 2003.
153. Wise, S. G., et al. A multilayered synthetic human elastin/polycaprolactone hybrid vascular graft with tailored mechanical properties. Acta Biomater. 7(1): 295-303, 2011.
154. Wolfe, P. S., et al. Evaluation of thrombogenic potential of electrospun bioresorbable vascular graft materials: acute monocyte tissue factor expression. J. Biomed. Mater. Res. A 92(4): 1321-1328, 2010.
155. Wootton, D. M., and D. N. Ku. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu. Rev. Biomed. Eng. 1: 299-329, 1999.
156. Yazdani, S. K., et al. Smooth muscle cell seeding of decellularized scaffolds: the importance of bioreactor preconditioning to development of a more native architecture for tissue-engineered blood vessels. Tissue Eng. Part A 15(4): 827-840, 2009.
157. Yow, K. H., et al. Tissue engineering of vascular conduits. Br. J. Surg. 93(6): 652-661, 2006.
158. Yu, X. X., C. X. Wan, and H. Q. Chen. Preparation and endothelialization of decellularised vascular scaffold for tissue-engineered blood vessel. J. Mater. Sci. Mater. Med. 19(1): 319-326, 2008.
159. Zaucha, M. T., et al. A novel cylindrical biaxial computer-controlled bioreactor and biomechanical testing device for vascular tissue engineering. Tissue Eng. Part A 15(11): 3331-3340, 2009.
160. Zetrenne, E., et al. Prosthetic vascular graft infection: a multi-center review of surgical management. Yale J. Biol. Med. 80(3): 113-121, 2007.
161. Zhang, X., V. Thomas, and Y. K. Vohra. In vitro biodegradation of designed tubular scaffolds of electrospun protein/polyglyconate blend fibers. J. Biomed. Mater. Res. B Appl. Biomater. 89(1): 135-147, 2009.
162. Zhang, W. J., et al. Tissue engineering of blood vessel. J. Cell. Mol. Med. 11(5): 945-957, 2007.
163. Zhang, L., et al. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds. Biotechnol. Bioeng. 99(4): 1007-1015, 2008.
164. Zhou, M., et al. Constructing a small-diameter decellularized vascular graft pre-loaded with bFGF. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(3): 370-375, 2008.
165. Zhou, M., et al. Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor. Artif. Organs 33(3): 230-239, 2009.
166. Zhou, M., et al. Beneficial effects of granulocyte-colony stimulating factor on small-diameter heparin immobilized decellularized vascular graft. J. Biomed. Mater. Res. A 95(2): 600-610, 2010.
167. Ziegler, T., and R. M. Nerem. Tissue engineering a blood vessel: regulation of vascular biology by mechanical stresses. J. Cell. Biochem. 56(2): 204-209, 1994.
168. Zilla, P., D. Bezuidenhout, and P. Human. Prosthetic vascular grafts: wrong models: wrong questions and no healing. Biomaterials 28(34): 5009-5027, 2007.
169. Zilla, P., M. Deutsch, and J. Meinhart. Endothelial cell transplantation. Semin. Vasc. Surg. 12(1): 52-63, 1999.
170. Zorlutuna, P., A. Elsheikh, and V. Hasirci. Nanopatterning of collagen scaffolds improve the mechanical properties of tissue engineered vascular grafts. Biomacromolecules 10(4): 814-821, 2009.